Assignee
AVENCELL EUROPE GMBH
DE·2 granted patents·2 pending applications·3 citations·filing 2018–2022
Top patents by PatentIndex Score
4 records- 0181US11560426B2Targeting modules for universal chimeric antigen receptor expressing immune cells and use in the treatment of cancer infections and autoimmune disordersAVENCELL EUROPE GMBH·Filed 2018·Granted Jan 24, 2023·3 cites·12 claims
- 0269US12173063B2Targeting modules for universal chimeric antigen receptor expressing immune cells and use in the treatment of cancer, infections and autoimmune disordersAVENCELL EUROPE GMBH·Filed 2022·Granted Dec 24, 2024·0 cites·14 claims
- 0349US2025302875A1TARGETING MODULES AGAINST IL13R-alpha-2 AND/OR HER2 FOR USE IN A METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR-MEDIATED IMMUNE RESPONSE IN A MAMMALAVENCELL EUROPE GMBH·Filed 2022·Application pending·0 cites
- 0448US2023183351A1A targeting module comprising pd-l1 and/or pd-l2 for use in a method for stimulating a chimeric antigen receptor mediated immune response in a mammalAVENCELL EUROPE GMBH·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AVENCELL EUROPE GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →